Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Kamala Harris blasts Trump administration’s capture of Venezuela’s...
Venezuelan dissident outlines risks and opportunities as Venezuela...
JONATHAN TURLEY: Maduro operation was legal, but Trump...
Dan Bongino officially leaves FBI deputy director role...
JONATHAN TURLEY: Why Trump went off script on...
Venezuela still owes US energy companies billions as...
9 Experts Share Highest-Conviction Sectors for 2026
Zinc Price Forecast: Top Trends for Zinc in...
Mamdani’s inauguration fuels debate over Gen Z shift...
DOGE says agencies cut $1.6B in federal contracts,...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Jackson scathing dissent levels partisan charge at colleagues after high-profile ruling

by admin August 23, 2025
August 23, 2025
Jackson scathing dissent levels partisan charge at colleagues after high-profile ruling

Justice Ketanji Brown Jackson criticized on Thursday what she said were the ‘recent tendencies’ of the Supreme Court to side with the Trump administration, providing her remarks in a bitter dissent in a case related to National Institutes of Health grants.

Jackson, a Biden appointee, rebuked her colleagues for ‘lawmaking’ on the shadow docket, where an unusual volume of fast, preliminary decisionmaking has taken place related to the hundreds of lawsuits President Donald Trump’s administration has faced.

‘This is Calvinball jurisprudence with a twist. Calvinball has only one rule: There are no fixed rules. We seem to have two: that one, and this Administration always wins,’ Jackson wrote.

The liberal justice pointed to the Oxford English Dictionary’s definition of Calvinball, which describes it as the practice of applying rules inconsistently for self-serving purposes.

Jackson, the high court’s most junior justice, said the majority ‘[bent] over backwards to accommodate’ the Trump administration by allowing the NIH to cancel about $783 million in grants that did not align with the administration’s priorities.

Some of the grants were geared toward research on diversity, equity and inclusion; COVID-19; and gender identity. Jackson argued the grants went far beyond that and that ‘life-saving biomedical research’ was at stake.

‘So, unfortunately, this newest entry in the Court’s quest to make way for the Executive Branch has real consequences, for the law and for the public,’ Jackson wrote.

The Supreme Court’s decision was fractured and only a partial victory for the Trump administration.

In a 5-4 decision greenlighting, for now, the NIH’s existing grant cancellations, Chief Justice John Roberts sided with the three liberal justices. In a second 5-4 decision that keeps a lower court’s block on the NIH’s directives about the grants intact, Justice Amy Coney Barrett, a Trump appointee, sided with Roberts and the three liberals. The latter portion of the ruling could hinder the NIH’s ability to cancel future grants.

The varying opinions by the justices came out to 36 pages total, which is lengthy relative to other emergency rulings. Jackson’s dissent made up more than half of that.

George Washington University law professor Jonathan Turley observed in an op-ed last month a rise in ‘rhetoric’ from Jackson, who garnered a reputation as the most vocal justice during oral arguments upon her ascension to the high court.

‘The histrionic and hyperbolic rhetoric has increased in Jackson’s opinions, which at times portray her colleagues as abandoning not just the Constitution but democracy itself,’ Turley said.

Barrett had sharp words for Jackson in a recent highly anticipated decision in which the Supreme Court blocked lower courts from imposing universal injunctions on the government. Barrett accused Jackson of subscribing to an ‘imperial judiciary’ and instructed people not to ‘dwell’ on her colleague’s dissent.

Barrett, the lone justice to issue the split decision in the NIH case, said challenges to the grants should be brought by the grant recipients in the Court of Federal Claims.

But Barrett said ‘both law and logic’ support that the federal court in Massachusetts does have the authority to review challenges to the guidance the NIH issued about grant money. Barrett joined Jackson and the other three in denying that portion of the Trump administration’s request, though she said she would not weigh in at this early stage on the merits of the case as it proceeds through the lower courts.

Jackson was dissatisfied with this partial denial of the Trump administration’s request, saying it was the high court’s way of preserving the ‘mirage of judicial review while eliminating its purpose: to remedy harms.’

This post appeared first on FOX NEWS

previous post
‘Leftist’ taxpayer-funded academy sparks backlash after moving against Trump’s rollback of key regulation
next post
Trump DOJ releases ‘thousands’ of Epstein files to House Oversight Committee

You may also like

Harris brings in big bucks in 24 hours...

September 13, 2024

Cruz clashes with Nigeria over his claims 50,000...

October 7, 2025

As world fixates on other wars, Sudan sees...

December 12, 2025

White House office tells agencies to apply ‘Gold...

June 23, 2025

Democrats opposed John Bolton for years — until...

August 25, 2025

Bernie Sanders says Israeli PM ‘wrong’ both in...

June 20, 2025

House Democrats open probe into FBI’s handling of...

September 11, 2025

CDC official includes ‘pregnant people’ terminology and pronouns...

August 29, 2025

Kristi Noem beats Senate confirmation hurdle, advancing to...

January 25, 2025

Dyan Cannon denied White House entry after lying...

August 31, 2025

Recent Posts

  • Kamala Harris blasts Trump administration’s capture of Venezuela’s Maduro as ‘unlawful and unwise’
  • Venezuelan dissident outlines risks and opportunities as Venezuela enters post-Maduro era
  • JONATHAN TURLEY: Maduro operation was legal, but Trump makes it complicated
  • Dan Bongino officially leaves FBI deputy director role after less than a year, returns to ‘civilian life’
  • JONATHAN TURLEY: Why Trump went off script on Venezuela and why it won’t matter

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (964)
    • Investing (3,786)
    • Politics (4,581)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.